Telehealth Intervention for Disruptive Behavior in Autism
(THRIVE-ASD Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a therapy called Parent-Child Interaction Therapy (PCIT) delivered through telehealth for young children with autism and disruptive behavior. The goal is to determine if ten sessions of this online therapy, known as Tele-PCIT, can improve behavior compared to regular treatment. Families will be randomly assigned to either the telehealth therapy or their usual treatment and will undergo assessments before and after the treatment, with a follow-up in three months. Children with autism who struggle with disruptive behavior and come from low-income backgrounds may be suitable for this trial. As an unphased trial, this study offers families the opportunity to explore a potentially beneficial therapy option that could enhance their child's behavior.
Will I have to stop taking my current medications?
If your child is taking psychotropic medications (medications that affect mood, perception, or behavior) and their medication routine has been stable for at least one month, they can continue taking them during the trial. If the medication routine is not stable, they may need to adjust it before participating.
What prior data suggests that Tele-PCIT is safe for children with autism?
Research has shown that Tele-PCIT, a type of Parent-Child Interaction Therapy conducted through telehealth, is generally well-received by families. Studies have found that this therapy not only helps manage disruptive behavior in young children with autism but is also accepted by parents. For example, one study found that parents felt more confident and less stressed when using telehealth methods with their autistic children. Additionally, previous research suggests that Tele-PCIT effectively reduces disruptive behaviors when used alongside other treatments.
While specific data on negative side effects is lacking, the therapy's acceptance by parents and its effectiveness suggest it is safe to use. The trial is labeled "Not Applicable" for phase, indicating the treatment is considered non-invasive and low-risk.12345Why are researchers excited about this trial?
Researchers are excited about the Tele-PCIT treatment because it offers a unique telehealth approach to managing disruptive behavior in children with autism, which can be more accessible and flexible for families compared to traditional in-person therapy. Tele-PCIT allows parents to engage in Parent-Child Interaction Therapy remotely, which can reduce barriers such as travel time and scheduling conflicts. This approach could potentially make effective behavioral interventions available to a wider audience, increasing the overall impact and reach of therapy for children with autism.
What evidence suggests that this trial's treatments could be effective for disruptive behavior in autism?
Research has shown that Tele-PCIT, or Parent-Child Interaction Therapy conducted online, can reduce disruptive behavior in young children with autism. In this trial, some participants will receive Tele-PCIT. One study found that parents noticed improvements in their children's behavior and experienced less stress. Another study demonstrated that Tele-PCIT helped these children develop better everyday skills. Early results also suggest that conducting PCIT over the internet effectively manages behavior problems in children aged 3 and up. Overall, these studies highlight the potential of Tele-PCIT as a promising treatment for disruptive behavior in children with autism.16789
Are You a Good Fit for This Trial?
This trial is for young children aged 2 to almost 7 with Autism Spectrum Disorder (ASD) who show disruptive behaviors. They must have a confirmed ASD diagnosis, understand language at a two-year-old level, come from low-income families on Medicaid, and not be on unstable psychotropic medications or exhibit severe self-injury.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive 10 sessions of Tele-PCIT or Treatment as Usual
Follow-up
Participants are monitored for safety and effectiveness after treatment
Post-treatment assessment
Assessment of child compliance, behavior problems, and parenting practices
What Are the Treatments Tested in This Trial?
Interventions
- Tele-PCIT
- Treatment as Usual
Find a Clinic Near You
Who Is Running the Clinical Trial?
Medical University of South Carolina
Lead Sponsor
Health Resources and Services Administration (HRSA)
Collaborator